CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 61 enrolled
Drug / intervention
LIFUP excitation +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06083493
NCT06083493N/ACompleted
CompareCT.gov

Neuromodulation of Conscious Perception: Investigating Thalamic Roles Through Ultrasonic Stimulation

University of Michigan·interventional·Posted Oct 16, 2023·Updated Nov 19, 2024

In Brief

A clinical study evaluating LIFUP excitation and LIFUP inhibition for Thalamus. Completed, enrolled 61 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the role that the thalamus (the egg-shaped structure in the middle of your brain) plays in perception using a low-intensity ultrasound pulsation (LIFUP) device. The researchers expect to observe differential changes in the perceptual outcomes based on the LIFUP stimulation of different thalamic areas

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsThalamus
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedOct 16, 2023
Enrollment StartNov 7, 2023
Primary CompletionMay 13, 2024
Study CompletionJun 13, 2024
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 2.7 years ago

Interventions

LIFUP excitationdevice

The experimental will consist of a 10-minute baseline period (LIFUP-OFF) followed by four 10-minute sessions of stimulating (LIFUP-ON-excitation) four thalamic areas. The order of thalamic area stimulation will be counterbalanced across participants and will include the ventral anterior (VA), dorsal anterior (DA), ventral posterior (VP), and dorsal posterior (DP) sections of the thalamus.

LIFUP inhibitiondevice

The experimental will consist of a 10-minute baseline period (LIFUP-OFF) followed by four 10-minute sessions of stimulating (LIFUP-ON-inhibition) four thalamic areas. The order of thalamic area stimulation will be counterbalanced across participants and will include the ventral anterior (VA), dorsal anterior (DA), ventral posterior (VP), and dorsal posterior (DP) sections of the thalamus.